AZAD continually invests into further development and expansion of its API portfolios. Process research on new APIs is performed under the supervision of AZAD’s chemists based in Switzerland, at our R&D labs in Armenia, allowing cost-effective development of innovative chemistry and polymorphic forms of APIs, that are then patent-protected. In addition, using the above facility and expertise, AZAD offers contract R&D for 3rd parties interested in synthetic route development of specific APIs.

Active Pharmaceutical Ingredients

Product Indication Remark
Bilastine Antihistamine
Ferric Carboxymaltose Iron deficiency Produced in Switzerland
Nelarabine Leukemia
Tafamidis ATTR-Amyloidose (CM and PN) New polymorph; produced in Switzerland